Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward

Globally, the death rate of pancreatic ductal adenocarcinoma (PDAC) has doubled over 30 years and is likely to further increase, making PDAC a leading cause of cancer-related death in the coming years. PDAC is typically diagnosed at an advanced stage, and modified FOLFIRINOX or nab-paclitaxel and ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Franck, Caspar, Müller, Christian, Rosania, Rosa, Croner, Roland S., Pech, Maciej, Venerito, Marino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409054/
https://www.ncbi.nlm.nih.gov/pubmed/32708493
http://dx.doi.org/10.3390/cancers12071955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409054/
https://www.ncbi.nlm.nih.gov/pubmed/32708493
http://dx.doi.org/10.3390/cancers12071955

Ejemplares similares